Hypertension Interventions Have Limited Success in Rural Black Populations
Hypertension remains a significant problem in areas of the rural South.
Commercial Plan Members Aren't Embracing Digital Health Tools
A survey found that patients satisfaction with the technology declined modestly in 2023, down 13 points on a 1,000-point scale.
Certain Antidepressants May Increase Lung Cancer Risk, Meta-Analysis Shows
Other research has suggested that SNRIs can lead to DNA damage, which the investigators said may be the avenue by which the drugs affect lung cancer risk.
Digital Health Leaders Propose New Guidelines For Product Evaluations
Existing evidence-evaluation frameworks are not sufficiently targeted toward the specific factors relevant to digital health products, they argue.
Myasthenia Gravis Patients Fare Better With COVID-19 When Vaccinated
Unvaccinated patients who were older at MG onset and at SARS-CoV-2 infection had more severe cases.
FDA Clears Adjunctive Virtual PTSD Therapy For Market
GrayMatters Health plans to use its technology for other mental health indications in the future.
Patient Metrics Improve With Diabetes App, But Engagement with Physicians May Be Key
A smartphone app is associated with improvement in HbA1c levels, but physician involvement with patients and other factors may be the benefit.
Digital Therapies Poised for Breakthrough in Migraine Treatment
The number of digital therapeutics available for migraine is likely to expand.
Health Tech to Look Out for in 2023
Preventive care, health insurance literacy and a digital health shakeout are in the crystal ball
Boost Medication Adherence With Personalized Solutions
Medication only works when it's taken, which makes adherence necessary. The approach can't be "one size fits all".
Addressing Medication Adherence May Also Mean Tackling Disparities
As a health plan worked to boost medication adherence among members, it made a startling discovery.
Diabetes Medications Find a Second Life as Weight-Loss Drugs
Novo Nordisk’s Saxenda (liraglutide) and Wegovy (semaglutide) are leading the way for a new crop of drugs that reduce appetite, but the cost-effectiveness is in question with many payers saying no to coverage.
Potential Drug-Diversion Cases Frequently Go Uninvestigated
Although one in 12 controlled substances medication transactions at US hospitals involve suspicious variations, only about half of such transactions are ever investigated.
Using Stimulants May Boost Buprenorphine Adherence in Patients with OUD
The findings paint a mixed picture, though, as stimulant use in patients with OUD was also associated with an increased risk of drug poisoning.
Sleep Device Market Remains Impacted by Philips CPAP Recall
The company is producing repair kits and replacement devices, but those efforts have led to a shortage of devices.
At-Home Outcomes Following Inpatient Rehabilitation for COPD Improved by Rehabilitation App
Data suggest a smartphone application can boost physical activity and relieve symptoms of chronic obstructive pulmonary disease.